Abstract:Background: Chronic kidney disease (CKD) is now globally recognized as a critical public health concern. Vascular calcification (VC) represents a significant risk factor for cardiovascular events in individuals with CKD. It is the accessible and precise diagnostic biomarkers for monitoring the progression of CKD and the concurrent VC are urgently needed. Methods: The adenine diet-induced CKD rat model was utilized to investigate chronic kidney injury, calcification in the kidney and thoracic aorta, and dysregulation of biochemical indices. Enzyme-linked immune sandwich assays were employed to analyze changes in calcification-related proteins. 16S rRNA sequencing was performed to delineate the microbiota characteristics in the gut and blood of CKD-afflicted rats. Additionally, transcriptome sequencing of kidney tissue was conducted to explore the relationship between CKD-associated microbiota features and alterations in kidney function. Results: The adenine diet-induced CKD inhibited body weight gain, and led to kidney injury, and pronounced calcification in kidney and thoracic aorta. The microbiota both in the gut and blood of these affected rats exhibited significantly lower alpha diversity and distinctive beta diversity than those in their healthy counterparts. CKD resulted in dysregulation of several biochemical indices (including elevated levels of creatinine, low-density lipoprotein-cholesterol, sodium, phosphorous, total cholesterol, and urea and decreased levels of albumin, calcium, lactate dehydrogenase, and total bilirubin). Moreover, it upregulated calcification-related factors (bone sialoprotein [BSP], Klotho, fibroblast growth factor [FGF]-23, and sclerostin [SOST]) and lipopolysaccharide (LPS). Notably, the increased Acinetobacter in the blood was positively associated with calcifications in the kidney and thoracic aorta, in addition to the positive correlation with gut microbiota. The enrichment of Acinetobacter was concurrent with increases in calcification factors (BSP, FGF-23, and SOST), LPS, and phosphorous. Furthermore, transcriptome sequencing revealed that the enrichment of Acinetobacter was positively correlated with the majority of upregulated genes and negatively correlated with downregulated genes involved in the mineral absorption pathway. Conclusion: Our findings, for the first time, underscore that dysbiosis of symbiotic microbiota, both in the gut and blood, is involved in the progression of CKD. Particularly, the enrichment of Acinetobacter in blood emerges as a potential risk factor for CKD and its accompanying VC.

Activation of Arterial Matrix Metalloproteinases Leads to Vascular Calcification in Chronic Kidney Disease

Wnt signaling contributes to vascular calcification by induction of matrix metalloproteinases

Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease

Vascular Calcification in Chronic Kidney Disease is Induced by Bone Morphogenetic Protein-2 Via a Mechanism Involving the Wnt/β-Catenin Pathway

Oxidative Phosphorylation Promotes Vascular Calcification in Chronic Kidney Disease

CKAP4 Contributes to the Progression of Vascular Calcification (VC) in Chronic Kidney Disease (CKD) by Modulating YAP Phosphorylation and MMP2 Expression

The Association Between Aortic Matrix Metalloproteinase-2 and Vascular Stiffness in Uremic Rats

Vascular Calcification is Associated with Wnt-signaling Pathway and Blood Pressure Variability in Chronic Kidney Disease Rats.

High phosphorus level leads to aortic calcification via β-catenin in chronic kidney disease

Impaired arterial vitamin D signaling occurs in the development of vascular calcification

Arterial "inflammaging" drives vascular calcification in children on dialysis

[Extracellular Matrix, Matrix-Degrading Proteases and Vascular Calcification].

Vascular Calcification in Chronic Kidney Disease: The Role of Vitamin K- Dependent Matrix Gla Protein

Key regulators of vascular calcification in chronic kidney disease: Hyperphosphatemia, BMP2, and RUNX2

Towards a better understanding of arterial calcification disease progression in CKD: investigation of early pathological alterations

In Chronic Kidney Disease Altered Cardiac Metabolism Precedes Cardiac Hypertrophy

Role of symbiotic microbiota dysbiosis in the progression of chronic kidney disease accompanied with vascular calcification

High Phosphate-Induced Downregulation of PPARγ Contributes to CKD-associated Vascular Calcification

Sclerostin is Involved in Osteogenic Transdifferentiation of Vascular Smooth Muscle Cells in Chronic Kidney Disease-Associated Vascular Calcification with Non-Canonical Wnt Signaling.

Vascular Remodeling and Arterial Calcification Are Directly Mediated by S100A12 (EN-RAGE) in Chronic Kidney Disease

High Mobility Group Box 1 Promotes Aortic Calcification in Chronic Kidney Disease Via the Wnt/β-Catenin Pathway.